Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27010019 | 0.91 | ALDH1A1 (0.41) | EPHX1ALDH1A1 | |
| SCHEMBL24316185 | 0.90 | ALDH1A1 (0.37) | EPHX1ALDH1A1 | |
| SCHEMBL27010014 | 0.88 | ALDH1A1 (0.36) | EPHX1ALDH1A1 | |
| SCHEMBL24316182 | 0.88 | ALDH1A1 (0.36) | EPHX1ALDH1A1 | |
| SCHEMBL27010021 | 0.84 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL25119720 | 0.84 | EPHX1 (0.36) | EPHX1 | |
| SCHEMBL24316184 | 0.76 | PIK3CD (0.35) | — | |
| SCHEMBL1911476 | 0.75 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL26628691 | 0.75 | EPHX1 (0.43) | EPHX1ALDH1A1 | |
| SCHEMBL26239730 | 0.75 | ALDH1A1 (0.40) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240018118-A1 | TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY | C 4 Therapeutics, Inc. (US) | 2024-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018118-A1 | TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY | NFATC1, CTSS, MMP12 | EPHX1 1980/4885ALDH1A1 2267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.